{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"8.33","value":"1.39"},{"groupId":"OG001","spread":"14.9","value":"1.25"},{"groupId":"OG002","spread":"89.5","value":"2.39"},{"comment":"Only 1 participant analyzed","groupId":"OG003","spread":"NA","value":"6.73"},{"groupId":"OG004","spread":"83.7","value":"4.22"},{"groupId":"OG005","spread":"24.5","value":"6.52"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"3"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Participants in Arm A received 60 mg dose of RO7297089 as a flat dose at each scheduled study drug administration visit","id":"OG000","title":"Dose Escalation Cohort 1: RO7297089"},{"description":"Participants in Arm A received 180 mg dose of RO7297089 as a flat dose at each scheduled study drug administration visit","id":"OG001","title":"Dose Escalation Cohort 2: RO7297089"},{"description":"Participants in Arm A received 360 mg dose of RO7297089 as a flat dose at each scheduled study drug administration visit","id":"OG002","title":"Dose Escalation Cohort 3: RO7297089"},{"description":"Participants in Arm A received 1080 mg dose of RO7297089 as a flat dose at each scheduled study drug administration visit","id":"OG003","title":"Dose Escalation Cohort 4: RO7297089"},{"description":"Participants in Arm B received the 1080 mg dose of RO7297089 as a split dose divided over two days (Days 1 and 2). The full target dose wasadministered at subsequent study drug administration visits.","id":"OG004","title":"Dose Escalation Backfill Cohort 4: RO7297089"},{"description":"Participants in Arm B received the 1850 mg dose of RO7297089 as a split dose divided over two days (Days 1 and 2). The full target dose was administered at subsequent study drug administration visits.","id":"OG005","title":"Dose Escalation Cohort 5: RO7297089"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Only those participants who received full dose were included in the results summary","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 1","title":"Half-life (t1/2) of RO7297089","type":"SECONDARY","unitOfMeasure":"day"}